Oncolytics Biotech Inc. Files 6-K Report
Ticker: ONCY · Form: 6-K · Filed: Aug 5, 2025 · CIK: 1129928
| Field | Detail |
|---|---|
| Company | Oncolytics Biotech INC (ONCY) |
| Form Type | 6-K |
| Filed Date | Aug 5, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, foreign-private-issuer, disclosure
Related Tickers: ONCY
TL;DR
ONCOLYTICS BIOTECH INC (ONCY) filed a 6-K, standard foreign private issuer report.
AI Summary
Oncolytics Biotech Inc. filed a Form 6-K on August 5, 2025, reporting as a foreign private issuer. The company, based in Calgary, Alberta, Canada, is in the Pharmaceutical Preparations industry and is subject to the 1934 Securities Exchange Act. This filing is for the month of August 2025 and indicates the company files annual reports under Form 20-F.
Why It Matters
This filing provides routine disclosure for foreign private issuers, informing investors about the company's ongoing reporting status and adherence to SEC regulations.
Risk Assessment
Risk Level: low — This is a routine filing for a foreign private issuer and does not contain specific financial or operational news that would inherently increase risk.
Key Players & Entities
- ONCOLYTICS BIOTECH INC (company) — Filer of the report
- August 2025 (date) — Reporting period for the 6-K
- 001-38512 (other) — SEC File Number
- Form 20-F (document) — Annual report filing type
- Calgary, Alberta, Canada (location) — Company's principal executive offices
FAQ
What is the purpose of a Form 6-K filing?
A Form 6-K is a report of foreign private issuers required to be filed with the SEC pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934, typically to provide information that the issuer makes or is required to make public in its home country.
What is the filing date and reporting period for this 6-K?
The filing date is August 5, 2025, and it is for the month of August 2025.
What type of annual report does Oncolytics Biotech Inc. file?
Oncolytics Biotech Inc. files its annual reports under cover of Form 20-F.
Where are Oncolytics Biotech Inc.'s principal executive offices located?
The company's principal executive offices are located at Suite 804, 322 11th Avenue SW, Calgary, Alberta, Canada T2R 0C5.
What is the SEC file number for Oncolytics Biotech Inc.?
The SEC file number for Oncolytics Biotech Inc. is 001-38512.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on August 5, 2025 regarding ONCOLYTICS BIOTECH INC (ONCY).